FDA approves Balfaxar, a Kcentra competitor for coagulopathy reversal

With postmarketing studies on the drug's safety profile to follow

Direct oral anticoagulants have not displaced warfarin and other vitamin K antagonists (VKAs), which remain the most commonly prescribed oral anticoagulants in older adults in the U.S.

Among the more than 2.4 million Americans taking daily warfarin, thousands experience warfarin-induced bleeding each year, and thousands more require urgent surgery or pr…